CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terry, P. D.
Right arrow Articles by Goodman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terry, P. D.
Right arrow Articles by Goodman, M.
Related Collections
Right arrow Epidemiology and Prevention
Right arrow Epidemiology and Prevention: Screening, Behavior, and Survivorship
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 602-611, April 2006
© 2006 American Association for Cancer Research

Is the Association between Cigarette Smoking and Breast Cancer Modified by Genotype? A Review of Epidemiologic Studies and Meta-analysis

Paul D. Terry and Michael Goodman

Department of Epidemiology, Emory University School of Public Health, Atlanta, Georgia

Requests for reprints: Paul D. Terry, Department of Epidemiology, Emory University School of Public Health, 1518 Clifton Road Northeast, Atlanta, GA 30322. Phone: 404-727-8715; Fax: 404-727-8737. E-mail: pdterry{at}sph.emory.edu

Epidemiologic studies have examined the association between cigarette smoking and breast cancer risk according to genotype with increasing frequency, commensurate with the growing awareness of the roles genes play in detoxifying or activating chemicals found in cigarette smoke and in preventing or repairing the damage caused by those compounds. To date, ~50 epidemiologic studies have examined the association between smoking and breast cancer risk according to variation in genes related to carcinogen metabolism, modulation of oxidative damage, and DNA repair. Some of the findings presented here suggest possible effect modification by genotype. In particular, 14 epidemiologic studies have tended to show positive associations with long-term smoking among NAT2 slow acetylators, especially among postmenopausal women. Summary analyses produced overall meta–relative risk (RR) estimates for smoking of 1.2 [95% confidence interval (95% CI), 1.0-1.5] for rapid acetylators and 1.5 (95% CI, 1.2-1.8) for slow acetylators. After stratification by menopausal status, the meta-RR for postmenopausal slow acetylators was 2.4 (95% CI, 1.7-3.3), whereas similar analyses for the other categories showed no association. In addition, summary analyses produced meta-RRs for smoking of 1.1 (95% CI, 0.8-1.4) when GSTM1 was present and 1.5 (95% CI, 1.1-2.1) when the gene was deleted. Overall, however, interpretation of the available literature is complicated by methodologic limitations, including small sample sizes, varying definitions of smoking, and difficulties involving single nucleotide polymorphism selection, which likely have contributed to the inconsistent findings. These methodologic issues should be addressed in future studies to help clarify the association between smoking and breast cancer. (Cancer Epidemiol Biomarkers Prev 2006;15(4):602–11)




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
K. Pirie, V. Beral, R. Peto, A. Roddam, G. Reeves, J. Green, and for the Million Women Study Collaborators
Passive smoking and breast cancer in never smokers: prospective study and meta-analysis
Int. J. Epidemiol., June 10, 2008; (2008) dyn110v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. B. Ambrosone, S. Kropp, J. Yang, S. Yao, P. G. Shields, and J. Chang-Claude
Cigarette Smoking, N-Acetyltransferase 2 Genotypes, and Breast Cancer Risk: Pooled Analysis and Meta-analysis
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
H. M. Ochs-Balcom, G. Wiesner, and R. C. Elston
A Meta-Analysis of the Association of N-Acetyltransferase 2 Gene (NAT2) Variants with Breast Cancer
Am. J. Epidemiol., August 1, 2007; 166(3): 246 - 254.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
P Vineis, F Veglia, S Garte, C Malaveille, G Matullo, A Dunning, M Peluso, L Airoldi, K Overvad, O Raaschou-Nielsen, et al.
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers
Ann. Onc., July 1, 2007; 18(7): 1230 - 1242.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. B. Spurdle, J.-H. Chang, G. B. Byrnes, X. Chen, G. S. Dite, M. R.E. McCredie, G. G. Giles, M. C. Southey, G. Chenevix-Trench, and J. L. Hopper
A Systematic Approach to Analysing Gene-Gene Interactions: Polymorphisms at the Microsomal Epoxide Hydrolase EPHX and Glutathione S-transferase GSTM1, GSTT1, and GSTP1 Loci and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 769 - 774.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.